Alight adds eMed to partner network to expand employer access to GLP-1 therapies
ALIT•Alight expands Partner Network for GLP-1 access
Alight added eMed Population Health to its Partner Network to broaden employer-sponsored access to GLP-1 weight-loss therapies.
The partnership targets scalable programs for eligible employees, with clinical evaluation, treatment access, adherence support and ongoing engagement.
The offering aims to help employers manage utilization, improve outcomes visibility and reduce avoidable healthcare spending tied to obesity care.
Gallup data cited in the brief said 11% of U.S. adults use GLP-1 drugs for weight loss, up from 3% in 2024.
